ArticleDiscover oncology2025
Evaluation of the efficacy of laparoscopic hepatolobectomy for primary liver cancer with early combined enteral and parenteral nutritional support.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The recovery of patients with liver cancer (LC) after laparoscopic hepatolobectomy is often affected by malnutrition, low immune function, and inflammatory responses, which may lead to an increase in postoperative complications and delayed recovery. Therefore, choosing a reasonable nutritional support plan is crucial for improving the postoperative recovery of patients. MATERIAL AND
methodOne hundred and fifty patients with primary LC who underwent laparoscopic hepatolobectomy were grouped: nutritional group (NG) and control group (CG). The NG implemented early enteral nutrition (EN) combined with parenteral nutrition (PN) support within 24 h postoperatively, while the CG only received early EN support. The liver function, nutritional indicators, plasma endotoxin levels, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) score, and postoperative recovery of the subjects were assessed.
resultCompared with the CG, the NG suggested visible improvement in postoperative aspartate aminotransferase (AST) and alanine aminotransferase (ALT), and a marked increase in albumin (ALB), prealbumin (PA), and total protein (TP). In addition, the plasma endotoxin levels were visibly lower, and the postoperative time to first bowel movement was visibly shortened in the NG as against the CG. There was no statistically meaningful distinction in hospital stay, time to ambulation, and time to first flatus in the subjects. The total score of the EORTC QLQ-C30 scale in the NG was significantly higher than that in the CG after intervention (P = 0.012). The overall incidence of complications in the NG was 6.7% (5/75), which was significantly lower than the 17.3% (13/75) in the CG (P = 0.042).
conclusionEarly EN combined with PN support can visibly improve the liver function and nutritional status of patients with primary LC after laparoscopic hepatolobectomy, promote postoperative immune recovery, and shorten recovery time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.